46results about How to "Improves wound healing" patented technology

Equol (7-hydroxy-3(4′hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5α-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies of skin and hair. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes affecting skin and hair.

A method for decreasing or shortening the length of time required to complete a surgical procedure by the application of hyaluronic acid to the surgical site, and for wound management by topical application of hyaluronic acid to a wound by syringe through a thin film dressing. The method of wound management results in accelerated wound healing time. The solution of hyaluronic acid may include an effective amount of a polysulfated glycosaminoglycan for stimulating macrophage activity at the surgical wound site.

The present invention provides systems and methods for treating wounds in patients who lack the innate ability to regulate glucose (e.g., diabetic patients). In one aspect of the invention, a method includes positioning an internal bypass device within the duodenum to inhibit contact between chyme passing therethrough and an internal wall of the duodenum and maintaining the internal bypass device within the duodenum for a sufficient period of time to decrease insulin resistance and reduce a blood glucose level in the patient. The internal bypass device increases peripheral blood flow and elevates an immune system response to accelerate healing of the wound.

The invention relates to pharmaceutical preparations made from marine collagens for inhibiting matrix metalloproteases and the use of a marine collagen for production of a pharmaceutical preparation for inhibiting matrix metalloproteases.

A wound healing system and a wound care bandage are provided. The wound care bandage has an electronics housing that houses a battery and wound care microcontroller. A bandage layer is provided and it defines a pad recess in which a pad is disposed. The pad has channels to allow for airflow. The wound care bandage at least first and second snap button electrodes, but there may be more snap button electrodes in other preferred embodiments. There are also electrically conductive adhesive strips with one being in contact with each of the first and second snap button electrodes. When current is controllably supplied to the first and second snap button electrodes a plurality of electric current flow paths are generated and that extend across the wound and stimulate the healing of the wound. The wound care bandage can be monitored and controlled wirelessly.

The invention provides EPS (Expandable Polystyrene) and mussel extract compounded skin barrier repairing dressing and a preparation method thereof. The EPS and mussel extract compounded skin barrier repairing dressing comprises the following raw materials in percentage by weight: 0.05%-0.12% of hyaluronic acid, 0.5%-0.8% of sodium alginate, 0.06%-0.15% of tremella heteropolysaccharide, 6%-8% of glycerol, 0.3%-1% of dihydric alcohol, 1%-2% of trehalose, 1%-2% of mannose, 0.02%-0.05% of lactic acid bacteria exopolysaccharide, 0.03%-0.08% of a mussel extract, 1%-2% of betaine, 1.5%-2.3% of amino acid, 1.8%-2.5% of PCA (pyrrolidone carboxylate) sodium, 0.01%-0.03% of a preservative, and the balance of water. According to the preparation method of the EPS and mussel extract compounded skin barrier repairing dressing, the lactic acid bacteria exopolysaccharide and the mussel extract are compounded, the tremella heteropolysaccharide, the trehalose, the mannose and the dihydric alcohol are combined, the betaine, the PCA sodium and the like are matched, and optimized proportion is adopted, so that the prepared dressing has good anti-inflammatory activity and high skin wound healing rate; and thus, the dressing can better and quickly repair damaged skin, has higher skin barrier repairing capacity, and is ensured with good tolerance.

This invention relates in general to a method and device for facilitating hemostasis and wound healing. In particular, the invention relates to the device comprising a polymeric material disposed on a scaffold that facilitates hemostasis and wound healing. Specifically, the invention contemplates the use of such scaffolds in conjunction with a negative pressure device.

The invention discloses a medical coating applied to an implanted medical instrument. The coating comprises a titanium-yttrium coating, a titanium nitride-yttrium alloy layer, a tantalum-yttrium coating and a tantalum-zinc-silver coating; the titanium-yttrium coating coats the outer layer of a base material of an implanted medical instrument; the titanium nitride-yttrium alloy layer coats the outer layer of the titanium-yttrium coating; the tantalum-yttrium coating coats the outer layer of the titanium nitride-yttrium alloy layer; and the tantalum-zinc-silver coating coats the outer layer of the tantalum-yttrium coating, wherein the tantalum-zinc-silver coating can be converted to a tantalum-magnesium-silver coating. The silver element of the medical coating can effectively inhibit generation of bacterial biofilms and inflammation, the zinc element and the magnesium element can effectively promote healing of wounds and growth of bone tissues, the yttrium element and the tantalum element can effectively improve fatigue resistance of a metal material, and the tantalum element can effectively enhance development performance of an X-ray machine. Harmful metal ions are embedded, so thatthe corrosion-resistant potential is improved, the biocompatibility is improved, electromagnetism of the metal implant is shielded, and CT diagnosis is realized.

The present invention provides a fusion protein in which a polypeptide comprising Fas-1 domain is fused in frame to N-terminal or C-terminal of human EGF, a nucleotide sequence encoding the fusion protein, an expression vector containing the nucleotide sequence, a transformant transformed by the nucleotide sequence and a method for producing human EGF, improving stability of the protein and enhancing the functions of the same. The present invention provides human EGF with improved stability and enhanced functions by fusing a polypeptide comprising Fas-1 domain having the activities of cell adhesion and wound healing to human EGF.

Devices, systems, and methods can be used for the closure of surgical wounds. For example, surgical wounds can be closed using magnetic closure devices rather than the conventional methods of using sutures, clips, or staples. Additionally, in some implementations the magnetic closure devices provided herein are delivered laproscopically or endoscopically via a vacuum catheter.

The invention discloses a composition with weight losing and beautifying effects. The composition comprises the following raw material: 1 to 10 parts of soybean peptide, 0.1 to 2 parts of collagen peptide, 0.1 to 2 parts of rose flower powder, 0.1 to 2 parts of polydextrose, 0.1 to 2 parts of grape seed extract, 0.1 to 2 parts of aloe vera extract, 0.1 to 2 parts of acerola cherry powder, 0.1 to 2parts of sodium hyaluronate, 0.1 to 2 parts of garcinia cambogia extract, 0.1 to 2 parts of apple polyphenol, 0.1 to 2 parts of pueraria flower extract, and 0.1 to 2 parts of betaine. With full consideration of the mutual synergistic effect of all the components, a proper propotion is provided; and after all components are compounded based on a proportion, the composition can be absorbed by thebody well and the mutual cooperation and synergistic interaction effects of the components can be fully exerted after the components are absorbed; a product having beautifying and weight losing effects is prepared; and problems that the skin loses elasticity due to fat reduction and collapses and the like can be solved.

The invention belongs to the technical field of material science, and particularly relates to a chitosan-gallic acid grafted copolymer as well as a preparation method and application thereof. The preparation method at least comprises the following steps: (1) carrying out low-temperature liquid-phase discharge plasma treatment on a mixed solution containing gallic acid and chitosan, wherein the discharge voltage of the low-temperature liquid-phase discharge plasma treatment is 8.5-9.5 kV; and (2) carrying out a post-polymerization reaction on the mixed solution having been subjected to low-temperature liquid-phase discharge plasma treatment. According to the method, a chemical cross-linking agent and an organic solvent are not used in the reaction process, meanwhile, the grafting rate of phenolic acid is high, green and environment-friendly effects are achieved, equipment is simple, and operation is convenient. The chitosan-gallic acid grafted copolymer prepared by the method has excellent antibacterial and wound healing accelerating capabilities, and can be widely applied as a rapid hemostatic sealant.

The invention belongs to the field of Chinese medicinal herb processing, and particularly relates to a processing method of a bletilla striata oral powder. The processing method comprises the following steps: preparing a material, peeling, performing heat treatment, drying, crushing and packaging. When the bletilla striata oral powder is prepared according to the processing method, bletilla striata is soaked in a special solution 1 and then radio frequency treatment is performed to promote the absorption of the bletilla striata for components in the solution 1, and the solution 1 reacts with substances in bletilla striata cells, so that the leaching rate of beneficial components of the bletilla striata is changed, the effective component content of a water extract is increased to a certainextent, therefore, the effects of treating pertussis and gastric ulcer and promoting wound healing by the bletilla striata are improved and the pertussis curing rate of the bletilla striata is as high as 76%.

The invention provides an ancient tree rejuvenating nutrient solution and a preparation method thereof, and relates to the technical field of the rejuvenation of ancient trees. The nutrient solution includes, by weight, 10-30 parts of potassium nitrate, 20-40 parts of ammonium phosphate, 5-20 parts of magnesium sulfate, 5-20 parts of zinc sulfate, 5-15 parts of copper sulphate, 4-10 parts of ammonium molybdate, 20-40 parts of potassium dihydrogen phosphate, 1-6 parts of EDTA ferric-sodium salt, 1-5 parts of boric acid, 3-12 parts of potassium iodide, 2-20 parts of indolebutyric acid, 5-15 parts of alpha-naphthalene acetic acid, 15-30 parts of radix euphorbiae lantu, 10-20 parts of common cnidium fruit, 10-20 parts of gerbera delavayi, 5-10 parts of radix Coix lacrymajobi, 5-10 parts of root of spiny raspberry, 30-80 parts of cane sugar, 0.1-0.5 part of vitamin, 2-7 parts of humic acid, and 4-8 parts of agricultural antibiotic. The preparation method of the nutrient solution is simple,and has good healing effects on problems of weak growing tendency of ancient trees, easy suffering of pest and disease hazards, slow wound healing, center of gravity deviation and unbalanced branch distribution.

The invention relates to seedling growing methods for pomegranates and especially relates to a cuttage seedling growing method for pomegranates in typical continental desert climate areas. Two years old pomegranate branches are clipped and cut into segments with equal length of 13 to 15 cm as cutting seedlings; one ends of the cutting seedlings are soaked in a rooting liquid for 42 to 48 hours and then inserted in cuttage holes; the cutting depth is 2 to 3 cm; space is filled with chernozem; the cutting holes are irrigated once with the rooting liquid every 5 days after cutting is completed. The cuttage seedling growing method for pomegranates is suitable for typical continental desert climate areas with drought and little rain, sharp temperature difference and strong sandy wind, and the method is of great significance in improving the survival rate of pomegranate cuttings in these areas.

The invention provides a method and formulation for the treatment or maintenance of conditions that would be benefited from increasing or maintaining Arginine levels in the blood, and having improved taste characteristics over current Arginine supplementations. Further, this maintenance of Arginine levels in the blood will be beneficial in acute and chronic diseases with an impaired arginine to citrulline production rate. Further the invention provides a method for treating at least one of satiety and dyspepsia in an individual. In one embodiment, the method includes administering to an individual an effective amount of L-citrulline.

The present invention is directed, in part, to methods of treating Epidermolysis Bullosa (EB) in a subject in need thereof, comprising topical administration of a pharmaceutical composition comprising a therapeutically effective amount of a of Coenzyme Q10 (CoQ10) to the subject.

Disclosed is an organic light-emitting device for light therapy for wound healing and cell proliferation, including: a substrate; an organic light-emitting device layer formed on the substrate and emitting red light; and a heat sink layer formed on the organic light-emitting device layer, which forms a red organic light-emitting device emitting red light in a stacking structure including a heat sink layer to generate light in a form of a planar light source which can be driven at a low temperature, thereby solving a problem of a burn and can perform light therapy through close contact with the skin.

The purpose of the present invention is to provide a specific wound healing accelerator effective for accelerating healing of wounds, particularly of wounds in the oral cavity, or a composition which includes the wound healing accelerator. This wound healing accelerator including a specific polyphenol is easy to handle and is capable of accelerating would healing even by contact for a short time.

The invention provides premix. The premix comprises, by weight percent, 200-300g of red ginseng powder, 200-300g of chitin, 10-20kg of spirulina powder, 8-12kg of lecithin, 500-800g of multivitamin, 500-800g of shell powder, 150-300g of talcum powder and 2-5kg of fish meal, or comprises, by weight percent, 200-250g of red ginseng, 200-250g of chitin, 10-15kg of spirulina powder, 8-10kg of lecithin, 500-700g of multivitamin, 500-700g of shell powder, 150-250g of talcum powder and 2-4kg of fish meal. The premix is simple in matching and convenient to use, immunity of chicken fed with the premix can be improved, drug resistance and side effect can be reduced, and consequential injury of human bodies by the premix is low.